ADP is not an agonist at P2X1 receptors:: evidence for separate receptors stimulated by ATP and ADP on human platelets

被引:126
作者
Mahaut-Smith, MP
Ennion, SJ
Rolf, MG
Evans, RJ
机构
[1] Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England
[2] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England
关键词
platelets; ADP; P2; receptors; P2X(1); purinoceptors; hexokinase; Ca2+;
D O I
10.1038/sj.bjp.0703517
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 ADP, an important agonist in thrombosis and haemostasis. has been reported to activate platelets via three receptors, P2X(1), P2Y(1) and P2T(AC). Given the low potency of ADP at P2X(1) receptors and recognized contamination of commercial samples of adenosine nucleotides, we have re-examined the activation of P2X, receptors by ADP following HPLC and enzymatic purification. 2 Native P2X(1) receptor currents in megakaryocytes were activated by alpha,beta-meATP (10 mu M) and commercial samples of ADP (10 mu M), but not by purified ADP (10-100 mu M). 3 Purified ADP (up to 1 mM) was also inactive at recombinant human P2X(1) receptors expressed in Xenopus oocytes. Purification did not modify the ability of ADP to activate P2Y receptors coupled to Ca2+ mobilization in rat megakaryocytes. 4 In human platelets, P2X(1) and P2Y receptor-mediated [Ca2+](i) responses were distinguished by their different kinetics at 13 degrees C. In 1 mM Ca2+ saline, alpha,beta-meATP (10 mu M) and commercial ADP (40 mu M) activated a rapid [Ca2+](i) increase (lag time less than or equal to 0.5 a) through the activation of P2X(1) receptors. Hexokinase treatment of ADP shifted the lag time by approximate to 2 s, indicating loss of the P2X(1) receptor-mediated response. 5 A revised scheme is proposed for physiological activation of P2 receptors in human platelets. ATP stimulates P2X(1) receptors. whereas ADP is a selective agonist at metabotropic (P2Y, and P2T(AC)) receptors.
引用
收藏
页码:108 / 114
页数:7
相关论文
共 57 条
[1]  
BEZPROZVANNY I, 1995, J MEMBRANE BIOL, V145, P205
[2]   The regulation of vascular function by P2 receptors: multiple sites and multiple receptors [J].
Boarder, MR ;
Hourani, SMO .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (03) :99-107
[3]  
Boeynaems Jean-Marie, 2000, Trends in Pharmacological Sciences, V21, P1, DOI 10.1016/S0165-6147(99)01415-7
[4]   P2 PURINOCEPTORS ON VASCULAR ENDOTHELIAL-CELLS - PHYSIOLOGICAL SIGNIFICANCE AND TRANSDUCTION MECHANISMS [J].
BOEYNAEMS, JM ;
PEARSON, JD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (01) :34-37
[5]   AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE AND ITS REVERSAL [J].
BORN, GVR .
NATURE, 1962, 194 (4832) :927-&
[6]   SOURCE AND CONCENTRATION OF EXTRACELLULAR ADENOSINE-TRIPHOSPHATE DURING HEMOSTASIS IN RATS, RABBITS AND MAN [J].
BORN, GVR ;
KRATZER, MAA .
JOURNAL OF PHYSIOLOGY-LONDON, 1984, 354 (SEP) :419-429
[7]   An antagonist-insensitive P-2X receptor expressed in epithelia and brain [J].
Buell, G ;
Lewis, C ;
Collo, G ;
North, RA ;
Surprenant, A .
EMBO JOURNAL, 1996, 15 (01) :55-62
[8]  
BURNSTOCK G, 1990, ANN NY ACAD SCI, V603, P1
[9]  
CHEN X, 1995, NAT STRUCT BIOL, V2, P2
[10]  
Daniel JL, 1999, THROMB HAEMOSTASIS, V82, P1322